Department of Hematology, Galway University Hospital, Galway, Ireland.
Bone Marrow Transplant. 2013 Nov;48(12):1543-7. doi: 10.1038/bmt.2013.109. Epub 2013 Aug 5.
Renal failure commonly complicates multiple myeloma (MM) and is associated with reduced survival. It is not clear whether auto-SCT results in improved renal function or attainment of independence from dialysis in patients with advanced renal impairment due to MM. We conducted a retrospective cohort study of all patients who underwent auto-SCT for MM complicated by advanced renal failure at our institution over a 10-year period (2000-2010). We aimed to assess the association between auto-SCT and renal outcome in patients with serum creatinine (SCr) over 3 mg/dL, attributable to MM, including those who were dialysis dependent. Thirty patients (2.8% of all auto-SCT patients) met inclusion criteria. Fourteen of 15 patients who were dialysis dependent before auto-SCT remained dialysis dependent in the long term despite hematological response (HR). Of the remaining 15 patients with SCr >3 mg/dL, an improvement in glomerular filtration rate (GFR) from 15 to 19.4 mL/min/1.73 m(2) was noted post auto-SCT (P=0.035); however, neither HR post auto-SCT or pre-existing renal function were independently associated with renal outcome. Auto-SCT was not associated with independence from dialysis in patients with renal failure due to MM at our institution. Although auto-SCT was associated with an improvement in GFR in patients with SCr >3 mg/dL, this improvement was not related to HR.
肾衰竭常并发多发性骨髓瘤(MM),并与降低生存率相关。目前尚不清楚自体造血干细胞移植(auto-SCT)是否会改善肾功能,或是否能使因 MM 导致的严重肾功能损害患者免于透析。我们对本机构 10 年内(2000-2010 年)所有因严重肾衰竭而行自体造血干细胞移植治疗的 MM 患者进行了回顾性队列研究。我们旨在评估自体造血干细胞移植治疗血清肌酐(SCr)>3mg/dL(归因于 MM,包括依赖透析患者)患者的肾功能结局。符合纳入标准的患者共 30 例(占所有自体造血干细胞移植患者的 2.8%)。15 例在自体造血干细胞移植前依赖透析的患者中,尽管有血液学反应(HR),但在长期内仍依赖透析。在剩余的 15 例 SCr>3mg/dL 的患者中,自体造血干细胞移植后肾小球滤过率(GFR)从 15ml/min/1.73m2 提高到 19.4ml/min/1.73m2(P=0.035);然而,HR 或移植前肾功能均与移植后的肾功能结局无相关性。本机构的自体造血干细胞移植治疗 MM 所致肾衰竭患者,并未使其免于透析。尽管自体造血干细胞移植治疗与 SCr>3mg/dL 患者的 GFR 提高有关,但这种改善与 HR 无关。